BBNX insider transactions
Beta Bionics Inc. (BBNX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for BBNX
- Director Jones Christy sold $39,354 worth of shares (2,811 units at $14.00) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 27,400 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Commercial Officer Hopman Mark sold $3,385 worth of shares (275 units at $12.31) as part of a pre-agreed trading plan, decreasing direct ownership by 0.21% to 130,612 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Product Officer Mensinger Mike sold $55,194 worth of shares (4,378 units at $12.61), decreasing direct ownership by 2% to 184,415 units (SEC Form 4) (tax liability)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Commercial Officer Hopman Mark sold $67,183 worth of shares (5,329 units at $12.61), decreasing direct ownership by 4% to 130,887 units (SEC Form 4) to satisfy withholding tax4 - Beta Bionics, Inc. (0001674632) (Issuer)
- President & CEO Saint Sean sold $212,707 worth of shares (16,872 units at $12.61), decreasing direct ownership by 4% to 420,937 units (SEC Form 4) to cover taxes4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Medical Officer Russell Steven Jon sold $53,227 worth of shares (4,222 units at $12.61), decreasing direct ownership by 2% to 173,849 units (SEC Form 4) to cover withholding tax4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Financial Officer Feider Stephen sold $84,165 worth of shares (6,676 units at $12.61), decreasing direct ownership by 4% to 166,053 units (SEC Form 4) to satisfy tax liability4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Director Palasis Maria was granted 16,965 shares, increasing direct ownership by 136% to 29,397 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Director Michel Gerard J was granted 16,965 shares, increasing direct ownership by 103% to 33,509 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Director Jones Christy sold $19,880 worth of shares (1,998 units at $9.95) as part of a pre-agreed trading plan and was granted 16,965 shares, increasing direct ownership by 98% to 30,211 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Director Dearen Danny L. was granted 16,965 shares, increasing direct ownership by 111% to 32,209 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Director Carney Sean was granted 16,965 shares, increasing direct ownership by 111% to 32,209 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Director Lezack Adam sold $9,950 worth of shares (1,000 units at $9.95) as part of a pre-agreed trading plan, was granted 16,965 shares and sold $11,188 worth of Comon Stock (998 units at $11.21) as part of a pre-agreed trading plan, increasing direct ownership by 120% to 27,399 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Medical Officer Russell Steven Jon sold $30,069 worth of shares (1,025 units at $29.34), decreasing direct ownership by 0.57% to 178,071 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Commercial Officer Hopman Mark sold $88,304 worth of shares (2,917 units at $30.27), decreasing direct ownership by 2% to 136,216 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Amendment: SEC Form 4 filed by Chief Commercial Officer Hopman Mark4/A - Beta Bionics, Inc. (0001674632) (Issuer)
- Amendment: SEC Form 4 filed by President & CEO Saint Sean4/A - Beta Bionics, Inc. (0001674632) (Issuer)
- Amendment: SEC Form 4 filed by Chief Medical Officer Russell Steven Jon4/A - Beta Bionics, Inc. (0001674632) (Issuer)
- Amendment: SEC Form 4 filed by Chief Product Officer Mensinger Mike4/A - Beta Bionics, Inc. (0001674632) (Issuer)
- Amendment: SEC Form 4 filed by Chief Financial Officer Feider Stephen4/A - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Commercial Officer Hopman Mark sold $4,084 worth of shares (353 units at $11.57), decreasing direct ownership by 0.25% to 139,133 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Medical Officer Russell Steven Jon was granted 109,105 shares and sold $12,683 worth of shares (1,026 units at $12.36), increasing direct ownership by 152% to 179,096 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- President & CEO Saint Sean was granted 343,269 shares and sold $41,832 worth of shares (3,384 units at $12.36), increasing direct ownership by 347% to 437,809 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Commercial Officer Hopman Mark was granted 109,105 shares and sold $10,310 worth of shares (834 units at $12.36), increasing direct ownership by 347% to 139,486 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Financial Officer Feider Stephen was granted 131,543 shares and sold $17,652 worth of shares (1,428 units at $12.36), increasing direct ownership by 305% to 172,729 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Product Officer Mensinger Mike was granted 109,105 shares and sold $13,153 worth of shares (1,064 units at $12.36), increasing direct ownership by 134% to 188,793 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Director Michel Gerard J was granted 3,997 shares, increasing direct ownership by 32% to 16,544 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Director Palasis Maria was granted 3,997 shares, increasing direct ownership by 47% to 12,432 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Director Carney Sean was granted 3,997 shares, increasing direct ownership by 36% to 15,244 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Director Lezack Adam was granted 3,997 shares, increasing direct ownership by 47% to 12,432 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Director Dearen Danny L. was granted 3,997 shares, increasing direct ownership by 36% to 15,244 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Director Jones Christy was granted 3,997 shares, increasing direct ownership by 36% to 15,244 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Product Officer Mensinger Mike sold $66,221 worth of shares (2,200 units at $30.10), decreasing direct ownership by 3% to 80,752 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Product Officer Mensinger Mike sold $230,950 worth of shares (7,800 units at $29.61), decreasing direct ownership by 9% to 82,952 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Financial Officer Feider Stephen exercised 20,000 shares at a strike of $5.10 and sold $590,680 worth of shares (20,000 units at $29.53) (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Product Officer Mensinger Mike sold $31,184 worth of shares (1,063 units at $29.34), decreasing direct ownership by 1% to 90,752 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- President & CEO Saint Sean sold $96,163 worth of shares (3,278 units at $29.34), decreasing direct ownership by 3% to 97,924 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Financial Officer Feider Stephen sold $41,862 worth of shares (1,427 units at $29.34), decreasing direct ownership by 3% to 42,614 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- SEC Form 4 filed by Beta Bionics Inc.4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Director Lezack Adam sold $41,543 worth of shares (1,406 units at $29.55), decreasing direct ownership by 14% to 8,435 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Director Lezack Adam sold $37,780 worth of shares (1,406 units at $26.87), decreasing direct ownership by 13% to 9,841 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Director Palasis Maria sold $37,834 worth of shares (1,406 units at $26.91), decreasing direct ownership by 13% to 9,841 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Financial Officer Feider Stephen exercised 4,982 shares at a strike of $5.10 and sold $108,076 worth of shares (4,982 units at $21.69) (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Financial Officer Feider Stephen exercised 15,018 shares at a strike of $5.10 and sold $311,806 worth of shares (15,018 units at $20.76) (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Financial Officer Feider Stephen exercised 9,900 shares at a strike of $5.10 and sold $209,151 worth of shares (9,900 units at $21.13) (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Commercial Officer Hopman Mark sold $370,837 worth of shares (18,229 units at $20.34) and exercised 16,160 shares at a strike of $5.10, decreasing direct ownership by 6% to 31,215 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Financial Officer Feider Stephen exercised 100 shares at a strike of $5.10 and sold $2,100 worth of shares (100 units at $21.00) (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- President & CEO Saint Sean sold $63,361 worth of shares (3,359 units at $18.86), decreasing direct ownership by 3% to 101,202 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Commercial Officer Hopman Mark sold $15,996 worth of shares (848 units at $18.86), decreasing direct ownership by 2% to 33,284 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Financial Officer Feider Stephen sold $27,578 worth of shares (1,462 units at $18.86), decreasing direct ownership by 3% to 44,041 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Product Officer Mensinger Mike sold $20,542 worth of shares (1,089 units at $18.86), decreasing direct ownership by 1% to 91,815 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Medical Officer Russell Steven Jon sold $19,146 worth of shares (1,015 units at $18.86), decreasing direct ownership by 1% to 71,017 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Financial Officer Feider Stephen sold $75,083 worth of shares (4,413 units at $17.01) and exercised 4,413 shares at a strike of $5.10 (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Financial Officer Feider Stephen exercised 5,587 shares at a strike of $5.10 and sold $95,172 worth of shares (5,587 units at $17.03) (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Commercial Officer Hopman Mark exercised 16,158 shares at a strike of $5.10 and sold $268,376 worth of shares (16,158 units at $16.61) (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Medical Officer Russell Steven Jon sold $18,588 worth of shares (1,039 units at $17.89), decreasing direct ownership by 1% to 72,032 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Product Officer Mensinger Mike sold $19,948 worth of shares (1,115 units at $17.89), decreasing direct ownership by 1% to 92,904 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Commercial Officer Hopman Mark sold $15,529 worth of shares (868 units at $17.89), decreasing direct ownership by 2% to 34,132 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- President & CEO Saint Sean sold $61,526 worth of shares (3,439 units at $17.89), decreasing direct ownership by 3% to 104,561 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)
- Chief Financial Officer Feider Stephen sold $26,783 worth of shares (1,497 units at $17.89), decreasing direct ownership by 3% to 45,503 units (SEC Form 4)4 - Beta Bionics, Inc. (0001674632) (Issuer)